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SUMMARY 
Title:  Congenital Ascites in Newborns 
Author:  Genta Zhubi 
Congenital ascites occurs when there is increased fluid build-up in the peritoneal cavity 
of the fetus.  It can occur in the setting of non-immune hydrops fetalis (NIHF) or be isolated. HF 
develops when fluid accumulates in extra-vascular areas and cavities of the fetal body.  
Examples of HF include a pericardial effusion, pleural effusion, ascites, placental growth and 
uniform skin thickening or skin edema. Congenital ascites can be diagnosed prenatally by an 
ultrasound exam, through which we are also able to find the cause of some cases of ascites.  
Biochemical and cytological laboratory analysis have been used in addition to the ultrasound 
exam, as these methods are more successful in identifying etiologies of congenital ascites. In this 
review paper, I will discuss several cases of congenital ascites in newborns, which have different 
etiological origin.  In the first case, a neonate presents with congenital chylous ascites and 
cholelithiasis due to maldevelopment of the lymphatic system. Next, a discussion of four cases 
will follow in which all neonates present with congenital ascites due to different lysosomal 
storage diseases. In the third case, a neonate presents with severe congenital ascites and is 
simultaneously diagnosed with autosomal recessive polycystic kidney disease (ARPKD).  The 
final discussion will focus on a series of 100 cases of congenital ascites for which biochemical 
and cytological testing were performed to identify the causes of ascites. 
Key words:  congenital ascites, non-immune hydrops fetalis, lysosomal storage diseases 
 
  
 
SAŽETAK 
Naslov:  Kongenitalni Ascites u Novorođenčadi 
Autor:  Genta Zhubi 
Kongenitalni ascites se javlja kada se tekućina nagomilava u peritonealnoj šupljini fetusa.  
Može se javiti u okviru neimunskog fetalnog hidropsa (NIHF) ili može biti izoliran. Fetalni 
hidrops (FH) se javlja kada se tekućina nakuplja u ekstravaskularnom prostoru i u šupljinama 
fetalnog tijela.  Primjeri fetalnog hidropsa su perikardijalni izljev, pleuralni izljev, ascites, 
prekomjerni porast placente i generalizirani edemi cijelog tijela. Kongenitalni ascites se može 
diagnosticirati prenatalno ultrazvučnim pregledom, i pomoću ultrazvuka u nekim slučajevima se 
može ustanoviti uzrok kongenitalnog ascitesa.  Osim ultrazvuka, razne biokemijske i citološke 
laboratorijske analize korisne su u razlučivanju etiologije kongenitalnog ascitesa. U ovom 
preglednom članku razmotrit ću nekoliko slučaja kongenitalnog ascitesa sa različitom 
etiologijom u novorođenčadi. U prvom slučaju riječ je o novorođenčetu sa kongenitalnim 
hiloznim ascitesom i kolelitijazom zbog poremećaja u razvoju limfatičnog sistema.  Sljedeća su 
četiri novorođenčeta sa kongenitalnom ascitesom čiji uzrok su bile lizosomske bolesti 
nakupljanja. Treći slučaj je novorođenče sa teškim kongenitalnim ascitesom koje je imalo 
autosomno recesivnu policističnu bolest bubrega. Na kraju analiziramo seriju od 100 objavljenih 
bolesnika sa kongenitalnim ascitesom koji su obrađeni temeljem biokemijske i citološke analize 
za otkrivanje uzroka ascitesa. 
 
Ključne riječi:  kongenitalni ascites, neimunskog fetalnog hidropsa, lizosomske bolesti 
nakupljanja  
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INTRODUCTION 
Hydrops fetalis (HF) has been acknowledged throughout time as a condition with pre-
natal and congenital presentations.  It occurs when there is increased fluid build-up in extra-
vascular areas and cavities of the fetal body.  In the fetus, a pericardial effusion, pleural effusion, 
ascites, placental growth, uniform skin thickening of more than 5 mm or skin edema are 
distinguishing for HF (2,6,8).  Two forms of hydrops fetalis are possible, the immunological and 
non-immunological forms. At the time when immunization of Rh negative mothers was 
inexistent, erythroblastosis caused by Rh alloimmunization was a source of an immunological 
form of hydrops fetalis.  This was the most common kind of HF. Nowadays, causes of hydrops 
fetalis vary and since erythroblastosis is no longer common, the phrase non-immune hydrops 
fetalis (NIHF) is used when referring to this condition. Up to 90% of reported events of HF are 
due to NIHF (11). 
HF normally includes fetal or congenital ascites as the main component of the clinical 
presentation (11).  Ascites appears when there is excessive fluid present in the peritoneal cavity 
of the fetus (2, 5, 6, 8). As a cause of different congenital diseases, fetal ascites may also occur as 
a separate entity without any fluid gathering in other body cavities.  However, the etiologies of 
primary congenital ascites are not well known. One likely, but quite rare explanation of 
congenital ascites is termed chylous ascites. Congenital lymphatic dysplasia or anomalous 
lymphatic drainage are two elements contributing to the cause of  chylous ascites. (NOSE) More 
precisely it is due to faulty development of the fetal lymphatic system, such as intestinal 
lymphangiectasia and agenesis or hypoplasia of lymph nodes. This form of ascites is responsible 
for approximately 4% of cases of congenital ascites. Other etiologies of congenital ascites that 
should be considered include:  congenital malformations, chromosomal aberrations, and 
  
 
  
 
2 
infectious diseases (5). Lysosomal storage diseases (LSD) are also included in the etiological 
spectrum of congenital ascites. LSD make up most of inborn errors of metabolism (IEM). Up to 
date, about 14 of such diseases are connected with NIHF and congenital ascites. It is speculated 
that HF and fluid build-up in the peritoneal space develop in patients with LSD due to a blockage 
of venous blood flow back to the heart.  This hindrance may occur because of an enlargement of 
visceral organs which was initially caused by aggregation of storage substances. Ascites may 
also be provoked by anemia. The mechanism involved is either decreased erythropoiesis or 
hypersplenism, due to an increased number of storage cells. Additional events that may lead to 
ascites in LSD include congestive heart failure, hypoproteinemia, and liver impairment (10, 11). 
This case review will investigate various cases of different anomalies or diseases 
diagnosed in newborns either congenitally or subsequently in the postnatal period, in which 
congenital ascites was a major component of the clinical picture.  It will focus on the possibility 
of these diseases or conditions having etiological factors on congenital ascites.  
In the first case, authors Siahanidou et al. describe a case of a newborn who presented 
with congenital chylous ascites and a ball-like formation in the gallbladder which later developed 
into gallstones (9).  Next, discussion will follow on four cases of inborn errors of metabolism in 
which hydrops fetalis and specifically congenital ascites were seen in the clinical picture, 
presented by authors Whybra et al. (11).  Another case report that will be discussed below is by 
authors Ling et al, in which a newborn with autosomal recessive polycystic kidney disease 
(ARPKD) presents with severe congenital ascites (7). Finally, diagnostic methods of congenital 
ascites will be described through a series of 100 cases presented by authors Dreux et al.  Ascites 
can be diagnosed using an ultrasound exam. However, due to its many and different causes, 
authors Dreux et al,, looked into alternate ways to diagnose this condition. Their investigation 
  
 
  
 
3 
was focused on biochemical and cytological methods of examining the fetal ascites fluid and 
their efficacy in determining possible etiologies (5).     
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CASE REPORTS 
Newborn with congenital chylous ascites and cholelithiasis  
A woman on the 18th week of pregnancy had an ultrasound exam which identified 
isolated fetal ascites.  The TORCH infections were excluded after amniotic fluid was analyzed. 
C-section was performed as per mother’s wish.  A male baby was delivered who weighed 3900 
grams. He followed with normal feeding by mouth for several days postnatally.  He was 
admitted on day 8 after birth, where he presented with a bloated abdomen and bilateral 
hydroceles. Lab work up for a complete blood count, electrolytes, total protein and albumin 
levels and kidney function showed normal results.  Peritoneal ascites was established upon 
performing an ultrasound on the abdomen. About 250 ml of fluid in the peritoneum were 
identified along with a ball-like formation in the gallbladder. 20 ml of ascitic fluid were 
withdrawn by paracentesis and analyzed.  White blood cell count showed a number of 3.8 x 
10
9
/L and triglycerides were found in the amount of 2.1 g/L.  Cytological analysis, Gram staining 
and culture did not show any abnormal results.  The newborn was diagnosed with chylous 
ascites. He began treatment with medium-chain triglycerides, given orally. Ascitic fluid 
decreased to about 60 ml after three weeks of therapy. After several sequential ultrasounds were 
performed, small gallstones were developing from the previous ball-like formation in the 
gallbladder.  Therapy with ursodeoxycholic acid was initiated with a dosage of 20 mg/kg/day. 
Several imaging techniques were performed in an attempt to find the etiology of chylous ascites. 
An MRI of the abdomen and thorax showed no abnormal findings.  Intestinal malrotation was 
excluded by an abdominal x-ray. No lymphatic pathology or abnormal tracer uptake of inguinal 
and iliac lymph nodes were found, based on lymphoscintigraphy. However, paraaortic lymph 
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nodes were unable to be viewed.  The etiology of gallstones was investigated and lab analysis 
excluded several hemolytic diseases, sepsis and malabsorption of the intestine, as the cause. The 
results of liver biochemical analysis were within the normal range. At the time the article was 
written, the baby was at the age of 8 months.  An ultrasound exam showed that he still contained 
about 50 ml of fluid in the peritoneal cavity. Additionally, three small gallstones were viewed of 
less than half of a centimeter in diameter, even though the baby continues the ursodeoxycholic 
medication. He had normal white and red blood cell counts (9). 
 
Four cases of congenital ascites in the presence of lysosomal storage disease 
A weight of 3250 g., length of 48 cm. and head circumference of 36 cm. were recorded 
for a male baby who was delivered on term. During the 24th week of pregnancy, the fetal 
ultrasound showed fetal hydrops along with ascites.  Fetal blood samples were used to eliminate 
prenatal infections or immunological etiologies. Chromosomal karyotyping for a male was 
normal after amniocentesis. The baby was breathing normally after delivery. Slight 
hepatosplenomegaly, bilateral inguinal hernia, and a usual outside appearance were noted, 
without pleural effusion or ascites.  The neonate had cholestasis and jaundice, including 
increased levels of direct bilirubin. A Hepato-IDA-scintigraphy revealed open biliary ducts 
outside of the liver. Foamy cells were present upon liver biopsy, which coincided with Niemann 
Pick disease. Enzymatic tests were performed to eliminate various LSDs such as, Neimann Pick 
disease (NPC), Gaucher disease and Wolman disease.  Ursodeoxycholic acid was used as 
therapy for cholestasis, which later cleared on its own. Necrosis of the femoral head on both 
hips, almost normal neurological progress, and slight joint contractures were seen on the male 
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infant. Due to this a slowly developing kind of NPC was considered. At the age of 8, the child 
was given a trial therapy of substrate reduction of NPC, which resulted in the exclusion of 
diagnosis for this disease.  Finally, a diagnosis of mucopolysacchardidosis (MPS) II was reached 
after the presence if corneal clouding, hip dysplasia, and deficiency of the β-glucuronidase 
enzyme (11).  
In the second case, fetal hydrops and extensive hydrothorax were present in the 22nd 
week of pregnancy.  After two weeks, the fluid was drained from the intrapleural place, under 
the assistance of ultrasound guided feto-amniotic shunting.  The female baby was delivered by 
C-section with weight, height, and head circumference of 3560 g., 52 cm, and 35 cm., 
respectively. A day after, the neonate presented with bradycardia and acrocyanosis at the 
neonatology ward where she was admitted.  A heart ultrasound and an ECG eliminated heart 
problems and infections were excluded. The patient’s walk was unsteady with weakness of 
quadriceps femoris and signs of kyphoscoliosis, at the age of three. A diagnosis of MPS IVA was 
confirmed after decreased levels of N-acetyl-glucosamin-g-sulfat sulfatase were found (11). 
In the third case, a child was born to parents of common ancestry.  Spontaneous abortion 
occurred in two pregnancies of the mother, prior to this one.  Intrauterine fetal hydrops was 
apparent. The baby was delivered by C-section, before term, on the 29th week of gestation.  At 
birth he weighed 1550 g., had a length of 41 cm., and a head circumference of 27.5 cm. The 
patient was able to walk at the age of 1 year and 8 months, but slight mental retardation was 
present.  Kyphoscoliosis was also seen around this time. After four years passed, the child was 
diagnosed with MPS IVA due to low levels of N-acetyl-glucosamin-6-sulfat sulfatase. This 
diagnosis was reached as the child was not showing any increase in length (remained below 3rd 
percentile) and skeletal anomalies were present (11). 
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In the fourth case, ascites was found on the 30th week of pregnancy.  There were no fetal 
infections or immunological causes of ascites in this male fetus.  Chromosomal karyotyping was 
normal as shown by amniocentesis. The baby was delivered on term on the 36th week of 
pregnancy.   The small amount of ascites that was present at birth cleared within the first couple 
of weeks. Neonatal jaundice and a slight increase in enzyme levels of a cholestatic liver 
continued for eight weeks.  A year after. a periodic check-up of the child revealed 
hepatosplenomegaly. There were high levels of the chitotriosidase enzyme, which led to a 
possibility of NPC. NPC was then confirmed due to the presence of storage cells from a bone 
marrow biopsy.  Additionally, a Filipin staining was positive and mutations were present on the 
NPC1 gene, further explained the diagnosis (11). 
 
Severe congenital ascites in the presence of autosomal recessive polycystic kidney disease 
A newborn female born on the 36th week of pregnancy with a weight of 2,700 grams.  
She presented with slight, right spontaneous pneumothorax and was taken into the NICU.  An 
ultrasound exam done around the 28th week of pregnancy showed an increased size of both 
kidneys and oligohydramnios.  The baby was experiencing respiratory distress and the increased 
size of kidneys was noted upon palpation. The pneumothorax subsided after administration of 
oxygen.  Polycystic kidney disease of the infantile type was diagnosed after both kidneys 
appeared larger than normal size and echogenic during an ultrasound exam. Both kidneys 
contained several cysts and calcifications appeared on parenchymal tissue.  Doppler ultrasound 
of the heart showed pulmonary hypertension, regurgitation through the tricuspid valve with a 
gradient of 58 mmHg. This cleared on its own, a week after birth. The infant also presented with 
congenital hypothyroidism approximately 6 weeks after birth and was treated with 
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levothyroxine.  On day five after birth, the newborn became hypertensive; the systolic blood 
pressure was 90 mmHg. Administration of hydralazine, captopril (ACE inhibitor) and 
propranolol (B-blocker) did not show complete success in lowering the blood pressure. Plasma 
renin activity was 4.66 ng/mL/hour and aldosterone levels were >120 ng/dL.  These values 
coincided with normal levels of a premature infant. The amount of urine produced was 0.6-1.0 
mL/kg/hour. Analysis of electrolyte levels showed hyponatremia with a sodium low of 123 
mEq/L. Ascites was apparent 2 weeks after birth, with moderate expansion of the abdomen. 
Paracentesis followed, and the fluid that was collected appeared clear, in an amount of 250 mL.  
Albumin levels in the blood were 2.6 g/dL. Portal hypertension was determined by the serum-
ascites albumin concentration gradient (SAAG) which was 1.9g/dL. This value determined portal 
hypertension. An ultrasound of the abdomen was done before paracentesis but it did not indicate 
portal hypertension or obstruction of hepatic veins. Three months after birth, twisted and 
enlarged bile ductules and an elevated number of bile ducts were seen upon liver biopsy.  The 
diagnosis of congenital hepatic fibrosis corresponded to these findings. Genetic analysis was 
performed to check for mutations of the PKHD1 gene, by taking the infant’s peripheral blood.  
There was a deletion on the maternal allele and a missense mutation on the paternal allele of the 
PKHD1 gene.  The treatment plan for the baby included:  propranolol in the amount of 
3mg/kg/day, furosemide, spironolactone, amlodipine, and captopril.  A percutaneous 
gastrostomy was performed and the tube was kept for 12 months until the baby was able to 
consume adequate amounts of food on her own.  At the time when the article was written, the 
child is 6 years and 8 months old. At the present time, she had hypertension which was managed 
with ramipril and propranolol and stage IV chronic kidney disease.  Additional medications and 
supplements that the child takes include: levothyroxine, growth hormone, sodium bicarbonate, 
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and supplements of vitamin D, α-D3, and calcium.  Also, at this time, the girl’s weight was 17.7 
kg and she was 107 cm tall.  These measurements both lied below the 5th percentile. At the age 
of 6 years and 7 months, the child experienced bleeding from the upper gastrointestinal tracts, 
casing her hemoglobin levels to fall to 4g/dL  Hypertensive gastropathy and esophageal varices 
were found after performing gastroscopy. This followed with ligation treatment of the varices 
and there was no reappearance of ascites (7). 
 
Retrospective study on 100 cases of congenital ascites 
A cohort study was conducted on 100 pregnant women, in which the fetuses were 
identified with ascites.  Ascites fluid was collected and they were sampled in the period between 
2006-2010. The volume of amniotic fluid, presence of HF, and presence of related abnormalities 
were investigated by an ultrasound exam.  Fetal chromosomal karyotyping was performed by 
amniocentesis. In this study, ascites was noted as a separate entity if no other malformations of 
the fetus existed. If HF was present, it was treated as a more serious form of ascites and not as an 
isolated condition.  Lab exams were performed on three different samples: maternal blood, 
amniotic fluid, and ascites fluid. Maternal blood was checked for blood group, agglutinin, blood 
count, and TORCH infections (syphilis, toxoplasmosis, rubella, herpes simplex, 
cytomegalovirus, parvovirus B19, and toxoplasmosis.  Using cytological testing, centrifugation 
of an ascites fluid sample was done, using cytopsin. Cell counting was done to check for the 
number of monocytes or macrophages, polymorphonuclear leukocytes, lymphocytes, and 
mesothelial cells. In addition, the amount of cytoplasmic vacuoles in lymphocytes was analyzed.  
These specific organelles were a sign of metabolic disease. Using biochemistry methods, 
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centrifugation was again performed on ascites fluid. The supernatant was collected and stored at 
a freezing temperature. Seven markers were to be identified using biochemistry investigations on 
the supernatant. These markers included:  total protein, β2 - microglobulin, total IgM, gamma-
glutamyl transpeptidase, aspartate aminotransferase, aminopeptidase M, and total alkaline 
phosphatase and its three isoenzymes.  During the time the study was done, 48 mothers aborted 
their pregnancy because of the presence of serious fetal abnormalities. Twelve mothers 
experienced a miscarriage. Forty mothers delivered a baby and those babies were investigated 
postnatally. In 31 of the fetuses there was a relation between ascites and HF.  Possible etiologies 
of ascites were categorized in eleven groups. The most repetitive causes included obstruction of 
the urinary tract and urogenital malformations. When observing the outcomes of biochemical 
markers, it was found that total protein and digestive enzyme activities showed decreased levels 
in ascites arising from urinary problems.  On the other hand, very high digestive enzyme activity 
levels were seen in ascites stemming from digestive abnormalities such as in peritonitis with 
perforation of the digestive tract. Ascites caused by CMV and parvovirus infections showed 
increased numbers in β2 - microglobulin.  High counts of lymphocytes were observed in chylous 
ascites and increased numbers of vacuoles were found in ascites caused by LSD such as 
sialidosis, Niemann–Pick disease type C, MPS VII, GM1 gangliosidosis, and galactosialidosis 
(5).  
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DISCUSSION 
In the patient with chylous ascites, lymphoscintigraphy showed that faulty development 
of the lymphatic system was the cause of ascites in this case.  Congenital chylous ascites is most 
often caused by such maldevelopment. The inability to visualize the paraortic lymph nodes in 
scintigraphy, was exhibitive of lymphatic dysplasia in that region.  It can be presumed that this 
dysplasia causes a disturbance in the small lymphatic vessels which in turn influences the flow of 
lymph into the peritoneal space. Common causes of cholelithiasis in newborns such as: 
hemolytic disorders, congenital anomalies of the biliary tree, prematurity, infection were not 
present in this baby.  As per authors’ knowledge, there was no previous case of a newborn 
presenting with both chylous ascites and gallstones. A theory could be possible as to why the two 
conditions occurred simultaneously. The paraaortic lymph nodes are the last lymph nodes which 
drain lymph into the gallbladder. If a disruption is existent within them, it could lead to an 
interruption of normal lymphatic flow within the gallbladder and development of gallstones.  
Still, the possibility of these two conditions occurring only by chance should also be considered. 
In this patient both chylous ascites and gallstones were handled conservatively. Octreotide 
medication which is known to restrict secretion of lymph was not used in this patient because of 
the possibility of causing gallstones, which the patient already had. Ursodeoxycholic acid was 
not successful in the separation of gallstones. A possible reason could be that this medication is 
not effective on black pigment bilirubinate gallstones, which is the most common composition of 
gallstones in children, compared to cholesterol ones which are present in adults.  At the time the 
article was written the patient remained asymptomatic but, in the future, he may need surgical 
treatment for chylous ascites or cholelithiasis or both (9). 
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Regarding the cases associated with LSD, a matter of doubt still exists of whether LSD 
are frequent in NIHF and congenital ascites.  Metabolic diseases can be a cause of many 
unidentified cases of NIHF and congenital ascites. For some LSD, if HF exists, it means that the 
most serious form of the disease is present.  Twelve types of LSD which are associated with 
NIHF include:  MPS IVA, MPS VII, GM1-gangliosidosis, type 2 Gaucher disease, NPA, NPC, 
Farber disease, Wolman disease, Sialidosis, Infantile sialic and storage disease, type II 
Mucolipidosis, and Sialidosis Galactosialidosis (11). Congenital ascites is often included as part 
of the clinical picture of LSD. There are a lot of arguments in various studies about what 
stimulates the build-up of excessive fluid in the peritoneum in newborns with LSD.  Factors that 
may lead to the presence of congenital ascites include anemia due to hypersplenism or decreased 
erythropoiesis. Additionally, liver abnormalities may lead to decreased protein production which 
in turn leads to ascites. Also, congestive heart failure and cirrhosis of the liver may cause ascites.  
Many times, a newborn presenting with ascites and who is later diagnosed with an LSD may 
have older siblings who are ill but were not diagnosed with the disease. LSD should always be 
investigated as a possible cause, if NIHF runs in families. An LSD is assumed if physical 
features such as facial dysmorphism, epiphyseal abnormalities, and coarse trabeculations of long 
bones exist together with congenital ascites (10).  The prevalence of LSD in those babies 
affected with ascites was measured to be 1.4% in a broad cohort study (3). LSD was investigated 
in 28 fetuses in utero who were identified to have NIHF, and 5 newborns who had HF. Five 
patients among these were diagnosed with an LSD, which included I-cell disease, Niemann-Pick 
type A, galactosialidosis, sialidosis, and MPS IVA. Only MPS IVA was diagnosed after birth, 
while the others were diagnosed in utero (4).  Patients affected with type 2 Gaucher disease in 
the presence of congenital ascites often have very low levels of the glucocerebrosidase enzyme.  
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The disease can also present with joint contractures. It is one of the most infrequent and serious 
of the LSD. Detailed investigation of the placenta is e key element when dealing with cases of 
ascites present in utero or postnatally.  Histological analysis of the placenta plays a great role in 
providing evidence for early diagnosis of LSD. Upon histological testing, if cells that contain 
numerous vacuoles or storage cells are identified, this is a hint to proceed with enzymatic testing 
for LSD.  Placental histological analysis has been able to detect GM1 gangliosidosis, MPS VII, 
ISSD, Gaucher disease, galactosialidosis, and Fabry disease (10).   
The case of ARPKD is also linked with portal hypertension.  When portal hypertension 
occurs in the liver, it is usually the first sign that ascites may follow.  One of the required criteria 
for portal hypertension is a portal pressure of 12 mmHg or more. Those patients who become 
symptomatic due to portal hypertension with show a deterioration in vascular and biochemical 
functions.  The patient in the case with ARPKD presented with slight pulmonary hypertension 
and tricuspid regurgitation which cleared at the end of the first postnatal week. Due to the ascitic 
fluid showing high SAAG levels, infections, intestinal obstruction, and chyle obstruction were 
excluded as causes of ascites.  Ling et al. point out the likelihood of primary sodium retention as 
a cause of ascites. This is linked to hypertension which is a prevalent symptom in the first few 
years in patients with ARPKD. Such a setting is possible even though serum creatinine levels 
appear normal. Mutations in the recessive allele of the PKHD1 gene are often seen in those 
affected with congestive heart failure (CHF).  A syndrome of ciliopathies exists in which CHF as 
well as biliary, hepatic, and kidney abnormalities are involved.  A transgenic PKHD1 gene was 
synthesized from mice who just like humans showed abnormalities of the pancreas, liver, and 
kidney.  This case is quite infrequent in the spectrum of etiologies of congenital ascites. 
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Nevertheless, if a newborn presents with ascites, CHF and ARPKD should be included in the 
differential diagnosis (7). 
Based on the study 100 cases discussed by Dreux et al., it was determined that the general 
prognosis of congenital ascites was feeble due to fetal or neonatal death observed in 60% of 
these cases.  It was shown in this study that laboratory analysis performed on the fetal ascitic 
fluid which was sampled in utero, succeeded in identifying 96% of causes of ascites that could 
not be identified by an ultrasound exam alone.  Using biochemical tests, it was observed that 
quite low levels of protein existed in the ascites that stemmed from urinary or genitourinary 
malformations. Three quarters of the cases showed protein levels at less than 10 g/L.  All ascitic 
cases which had a digestive cause displayed quite high levels of digestive enzyme activity. 
Ascitic fluid which had an infectious cause showed high β2-microglobulin levels in all samples.  
Cell count investigations were utilized to determine the percentage of lymphocytes in the sample 
of ascitic fluid.  Ascites of of chylous origin was assumed, if the amount of lymphocytes in a 
sample was 80% or more. Nevertheless, one cannot be based on this test to determine that 
lymphatic dysplasia is the cause of chylous ascites.  Increased numbers of vacuoles in cells were 
seen in ten cases, which indicates that metabolic storage diseases could be the cause. Out of the 
ten cases, five different lysosomal storage diseases were found in five of the cases.  These 
diagnoses were verified by performing different biochemical analysis on amniotic fluid (5). 
In this study the presence of ascites was identified in all cases by an ultrasound exam.  
Furthermore, the ultrasound exam was successful in identifying ascites caused by cardiac 
abnormalities in 100% of the cases.  In 92% of the cases it identified ascites caused by urinary 
and genitourinary abnormalities and ascites of digestive origin was caught in only 28% of the 
cases.  HF was observed in 40% of the cases with lysosomal storage diseases. Moreover, a  
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relation with HF was seen in all of the etiologies of congenital ascites described in this study.  
Due to this, the presence of HF should indicate an extent of severity of ascites and not be linked 
with a certain cause of ascites. In 50% of the cases in this study, the ultrasound exam was unable 
to identify the etiology of ascites.  In such an event, the ultrasound must be accompanied by a 
Doppler exam of the MCA-PSV and fetal anemia should be investigated. If there is serious fetal 
anemia present, in utero blood transfusion should be carried out. At this time percutaneous 
umbilical blood sampling (PUBS) can be done to perform cell counting.  This sample can be 
analyzed for the present of stomatocytosis. Xerocytosis, a dehydrated form of stomatocytosis 
exists, which may cause HF.  In most cases, fetal blood is not checked for this condition, which 
means that some etiologies of congenital ascites are undervalued. In this study infectious 
diseases as a cause of ascites were seen in 6% of the cases, demonstrating the importance of 
checking for TORCH infections (5).  Fetal karyotyping is another key element when deducing 
the cause of ascites, as there have been cases of aneuploidy and congenital ascites seen in the 
same baby (1). Based on the results of this study, there is a plan that consists of two steps in 
controlling pregnancies. In the first step, there are three additional sub-steps.  They include:  
performing an ultrasound exam which includes the Doppler and MCA-PSV, blood work of 
maternal blood, and fetal karyotyping.  In the second step ascitic fluid is checked through 
biochemical and cytological testing.  In 63% of the cases, the cause of ascites was identified by 
performing the procedures in the first step alone. When the procedures of the second step were 
added, the etiology of ascites was identified in 96% of the cases.  There were four cases of 
ascites that were not identified by these methods and those were three cases of genetic 
syndromes and one case of pulmonary sequestration.  One weakness of this study was the fact 
that it was retrospective.  This way the medical personnel involved in the investigation chose 
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those cases of ascites that were most challenging to them and did not reveal all cases of NIHF 
(5). 
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CONCLUSION 
Hydrops fetalis develops when there is increased fluid accumulation in extra-vascular 
areas and cavities of the fetal body. If noticed in utero, a pericardial effusion, pleural effusion, 
ascites, placental growth, uniform skin thickening of more than 5 mm or skin edema are 
distinguishing for HF.  In this case review the focus was on the non-immunological form of HF. 
Congenital ascites is an important clinical sign of HF. Ascites appears when there is excessive 
fluid present in the peritoneal cavity of the fetus. The etiologies of congenital ascites are not 
always clear and acknowledged.  The causes of congenital ascites as mentioned in the cases 
include maldevelopment of the lymphatic system causing chylous ascites, autosomal recessive 
polycystic kidney disease, and lysosomal storage diseases. Though ascites can be diagnosed 
prenatally by an ultrasound exam, biochemical and cytological investigations have shown to be 
more successful in the ability to diagnose more cases of congenital ascites than the ultrasound 
exam.    
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